|
Volume 271, Number 48,
Issue of November 29, 1996
pp. 30790-30797
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Characterization of a Leucine Zipper-containing Protein
Identified by Retroviral Insertion in Avian Neuroretina Cells*
(Received for publication, June 21, 1996, and in revised form, September 12, 1996)
Véronique
Proux
,
Sylvain
Provot
,
Marie-Paule
Felder-Schmittbuhl
,
Danielle
Laugier
,
Georges
Calothy
and
Maria
Marx
§
From the Unité Mixte de Recherche 146 du CNRS, Institut
Curie, Laboratoire 110, Centre Universitaire,
91405 Orsay Cédex, France
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES
ABSTRACT
We reported previously that post-mitotic chicken
embryonic neuroretina (NR) cells are induced to proliferate following
in vitro infection with RAV-1, a retrovirus that does not
carry an oncogene. NR cell multiplication results from the frequent
activation and subsequent retroviral transduction of two related
serine/threonine protein kinases, the
c-mil/c-raf or
c-Rmil/B-raf genes. We also showed that a very
early event in the activation of these proto-oncogenes is the synthesis
of chimeric mRNAs containing viral and cellular sequences joined by
a splicing mechanism. In the current study, we have examined the
ability of RAV-1 to induce proliferation of quail NR cells. By using
the reverse transcription-polymerase chain reaction technique, we
identified, in several proliferating quail NR cultures infected with
RAV-1, a chimeric mRNA containing cellular sequences joined to the
RAV-1 splice donor site. These cellular sequences are derived from a
gene designated R10, which is expressed through a
1.9-kilobase (kb) mRNA detected in several embryonic tissues. A
second transcript of 2.3 kb is specifically expressed in the NR, where
both transcripts are developmentally regulated. The R10 cDNA
encodes a 251-amino acid polypeptide that contains a leucine zipper
motif. It exhibits significant similarity with the putative D52/N8L
protein, encoded by an mRNA reported previously to be overexpressed
in human breast and lung carcinomas. By using polyclonal antibodies
specific for its amino-terminal and leucine zipper-containing regions,
we identified the R10 gene product as a cytoplasmic protein
of 23 kDa in cultured avian fibroblasts. A second protein of 30 kDa is
detected in post-mitotic NR cells that express the 2.3-kb transcript.
We also show, by in vitro transcription/translation and
immunoprecipitation, that the R10 protein can readily form homodimers,
presumably through its leucine zipper motif.
INTRODUCTION
The study of transcriptional activation of cellular genes,
following integration of retroviruses in the host cell genome, constitutes a powerful experimental approach for identifying genes potentially involved in proliferation or differentiation processes (1).
We reported previously that post-mitotic chicken embryonic neuroretina
(NR)1 cells can be induced to proliferate
following infection with the avian lymphomatosis virus Rous-associated
virus type 1 (RAV-1), which does not carry an oncogene. NR cell
proliferation results from the frequent transcriptional activation and
reproducible retroviral transduction of two related serine/threonine
protein kinases, the c-mil/c-raf or
c-Rmil/B-raf proto-oncogenes (2, 3, 4). We showed
that these events involve the synthesis, early after infection, of
readthrough transcripts containing viral and cellular sequences
belonging to either proto-oncogene, presumably located downstream from
the integrated RAV-1 provirus. Alternative splicing of these
transcripts generates hybrid mRNAs that contain the catalytic
domain of these proto-oncogenes and express mitogenic capacity when
introduced into nondividing NR cells (5). Although RAV-1 also induces
proliferation of quail embryonic neuroretina (QNR) cells with the same
efficiency, we have never observed retroviral transduction of
c-mil/c-raf and/or
c-Rmil/B-raf in proliferating QNR cells, despite
the presence of chimeric mRNAs early after infection with
RAV-1.2 This suggested that other genes
activated by retroviral insertion could be responsible for QNR cell
proliferation. Therefore, we undertook the characterization of such
chimeric mRNAs in proliferating QNR cells infected with RAV-1 in
attempt to identify genes that may play a role in regulating
proliferation of these cells.
We report the isolation and characterization of a readthrough
transcript containing viral and cellular sequences joined by a splicing
mechanism. This mRNA, detected in several RAV-1-infected QNR
cultures, corresponds to a gene, designated R10, the
expression of which is developmentally regulated in the neuroretina. It
encodes a protein of 251 amino acids that contains a leucine zipper
motif and forms homodimers. By using different R10-specific
antisera, we identified the R10 gene product as a 23-kDa
cytoplasmic protein in cultured avian fibroblasts. A second protein of
30 kDa is detected in post-mitotic NR cells. R10 protein exhibits
significant similarity with the putative protein encoded by the
D52/N8 human gene, shown to be overexpressed in
breast and lung carcinomas (6, 7).
EXPERIMENTAL PROCEDURES
Cell Cultures and Viruses
QNR cell cultures were prepared
from 7-day-old Japanese quail (Coturnix coturnix japonica).
Cultures were maintained and passaged as described previously (8).
Chicken and quail embryo fibroblasts were prepared and grown as
described (9). RAV-1/OR is a subgroup A lymphomatosis virus (10).
DNA Purification and Restriction Enzyme
Analysis
High-molecular-weight DNA was purified by standard
procedures (11). Plasmid DNAs were purified on Qiagen columns. DNAs
were digested with restriction enzymes under conditions recommended by
the suppliers (New England Biolabs and Appligene), analyzed by Southern
blotting (12), and hybridized under stringent conditions (13) with
probes radioactively labeled by the random priming technique (14).
RNA Isolation and Northern Blot Analysis
Total RNA from
cultured cells or tissues was isolated either by the guanidium
thiocyanate-cesium chloride method (15) or with the RNA NOW reagent
(Biogentex). Northern blot analysis of RNAs and hybridization were
performed as described previously (3).
Screening of cDNA Library
Polyadenylated RNA prepared
from 13-day-old embryonic quail neuroretina (QNR) was used to construct
an oligo(dT)-primed cDNA library in gt10 vector (16). This
library was screened with cell-derived sequences of Cl10 as described
(14). Four independent clones (1.1, 50, 80, and 8) were further
amplified and analyzed. EcoRI inserts were subcloned into
the EcoRI site of pUC18 vector.
Identification of cDNA 5 End by Polymerase Chain
Reaction
Single-stranded cDNA was synthesized from 5 µg of
total RNA prepared from 13-day-old embryonic quail neuroretina using
the "cDNA cycle kit for RT-PCR" (Invitrogen). Synthesis was
initiated with a 18-mer R10-specific primer (5 -TGTAGCAGCAGCATCCTC-3 ). The products were concentrated and purified with Centricon 30 (Amicon).
A poly(dA) tail sequence was added with terminal deoxynucleotidyl transferase (Stratagene) under conditions recommended by the supplier. Reaction products were purified and concentrated using Centricon 30 to
a final volume of 55 µl. A 12-µl aliquot was used for amplification by polymerase chain reaction (PCR) with the two following primers: a
18-mer R10-specific primer (2013, 5 -GCGACTTGTAATCCTCGT-3 ) and a
26-mer primer for the poly(dA) end (ENT5,
5 -CGATATCGCGAT15-3 ). PCR products were cloned into the
pCRII T/A cloning vector (Invitrogen).
cDNA Synthesis and Amplification by Polymerase Chain
Reaction
Single-stranded cDNA was synthesized from 5 µg of
total RNA by using the "cDNA cycle kit for RT-PCR"
(Invitrogen). Synthesis was initiated either from oligo(dT) primer or
from R10-specific primers. One-fourth of each reverse transcriptase
reaction was amplified using leader-specific and either poly(dA)
(ENT5)- or R10-specific primers.
Quail genomic DNA was amplified according to the "Expand Long
Template PCR System" (Boehringer Mannheim). Primers (r3, r4, r5, r6,
r7, and r8) flanking S1, S2, and S3 splice acceptor sites are shown in
Fig. 3. PCR products were analyzed by Southern blotting and
hybridization with 5 end-labeled specific oligonucleotides (2013, r7,
and r6). They were cloned into pCRII (Invitrogen) or pMOSBlue (Amersham Corp.) T/A cloning vectors.
Fig. 3.
Chimeric gag-R10 mRNAs are generated by a
splicing mechanism. A, amino acid sequence of the putative
Gag-R10 protein. The leucine zipper motif is dashed.
Gag-specific amino acids are boxed. B, splice
junctions between RAV-1 leader and R10 sequences. The sequences of
chimeric mRNAs identified in proliferating QNR cultures by RT-PCR
were compared with those of RAV-1 and the R10 gene. The
splice acceptor sites of the R10 gene are identified according to consensus sequences of Breathnach and Chambon (50).
[View Larger Version of this Image (41K GIF file)]
DNA Sequencing
cDNA clones and PCR products were
sequenced on both strands by the dideoxychain termination method using
the "T7 sequencing kit" (Pharmacia Biotech Inc.) (17).
Construction of Tagged R10 Protein-expressing Vector
The
coding region of R10 cDNA clone 50 (Fig. 2) was fused in-frame at
its 3 end with the DNA fragment encoding the nine-residue epitope of
the HA1 influenza virus hemagglutinin by polymerase chain reaction.
Primers used were: 2017 (5 , 5 -GCCGCCACCATGGTGGCGGTGCTCTCAGAG-3 ) and
2019 (3 , 5 -TCAGAGGCTAGCATAATCAGGAACATCATATGTTGTCTCCTC-3 ). Primer
2017 introduces a better Kozak consensus sequence for initiation of
translation upstream from the native translation initiation codon of
R10 cDNA (18, 19). Primer 2019 removes the stop codon of R10
protein and introduces another one downstream from the inserted HA1
sequence. The PCR product was cloned into pMOSBlue vector
(Amersham Corp.), sequenced, digested with
BamHI/HindIII and inserted into the pECE vector
(20) between BglII and HindIII sites (Fig.
4A). These constructs were used to transfect COS-1 cells by
the DEAE-dextran-chloroquine method (21) as described previously
(22).
Fig. 2.
A, organization of quail R10 cDNA
clones. The ATG translation initiation codon and the stop codon are
indicated. The alternative exon in clone 1.1 is indicated by a
dashed square. B, nucleotide and deduced amino
acid sequence of quail R10 cDNA. Nucleotide 1 of the sequence
corresponds to the first nucleotide of the anchor PCR cDNA. The ATG
and the TGA are shown in bold. The stop codon is indicated
by an asterisk. Alternative exons are underlined. The leucine zipper motif is dashed. Primers (r) used for
RT-PCR and PCR are indicated by arrows. S1, S2, and S3
indicate the junction sites of R10 with the RAV-1 leader sequence. The
two polyadenylation signals are shown in bold within the 3
untranslated region. C, comparison of the amino acid
sequences of R10, N8L, and N8/D52 proteins. Hyphens indicate
identical amino acids. Asterisks indicate amino acids absent
in N8L and N8/D52 proteins.
[View Larger Version of this Image (53K GIF file)]
Fig. 4.
Characterization of HA1-tagged R10 protein.
A, vector for expression of epitope-tagged R10 protein.
Construction of this vector is described under "Experimental
Procedures." The boxed amino acids correspond to the HA1
epitope. 2017 and 2019 are primers used for PCR. B,
expression of HA1-tagged R10 proteins. Lysates of COS-1 cells
transfected with pECE vector alone ( ) or with HA1-R10 cDNA (+)
were analyzed for the expression of the epitope-tagged R10 protein.
Lysates were immunoprecipitated (IP) with 12CA5, LZ, or PR
antibodies, resolved by SDS-PAGE (15% gel), and immunoblotted
(WB) with the 12CA5 antibody. C, R10-specific antibodies recognize HA1-tagged R10 proteins. Proteins extracted as
described in B were immunoprecipitated with preimmune
(PI), LZ, or PR antisera. After SDS-PAGE, they were
immunoblotted with LZ antiserum.
[View Larger Version of this Image (31K GIF file)]
Preparation of R10-specific Antisera
Two regions of the
coding sequence of R10 cDNA were subcloned in-frame to sequences of
the pLC24 bacterial vector (23) by PCR amplification, using as template
R10 cDNA Cl50. The region encoding amino acids 26 to 64 (PR serum)
was amplified, using as primers AC1 (5 -GATTTGGATCCAGGAGTGGAC-3 ) and
AC2 (5 -GCAGAAGCTTACTCTCCAAC-3 ). The region encoding amino acids 67 to
132 (LZ serum) was amplified by using as primers AC3
(5 -GAGAGGATCCTGCTGCTAC-3 ) and AC4 (5 -GTCAAAGCTTACCAGCT-3 . Amplified
fragments were sequenced, digested with
BamHI/HindIII, and inserted into pLC24 between
BamHI and HindIII sites. Purification of the
bacterial proteins and preparation of antisera in rabbits were done as
described previously (24, 25).
Immunoprecipitation and Western Blotting
Cell lysates
prepared as described previously (22) were analyzed by
immunoprecipitation using either HA1 monoclonal antibody (26) or
R10-specific antisera, followed by SDS-PAGE electrophoresis and Western
blotting. Proteins were detected by chemiluminescence under the
conditions recommended by the supplier (Amersham Corp.).
Immunofluorescence
COS-1 cells (2.5 × 104) transfected with either pECE R10-HA1 or control pECE
vector were seeded in 8.9 × 8.9-mm wells on 26 × 76-mm
plastic coverslips (Laptek Chamber; Nunc). Forty-eight h later, cells
were fixed with 3.5% paraformaldehyde in phosphate-buffered saline
(PBS) for 20 min and permeabilized by treatment with 0.25% Triton
X-100 in PBS for 20 min at room temperature. After a 10-min treatment
with 5% fetal calf serum in PBS, cells were incubated for 1 h
with 12CA5 monoclonal anti-HA1 antibody at room temperature. They were
then incubated with fluorescein isothiocyanate-conjugated goat
anti-mouse IgG secondary antibodies (Sigma) for 1 h, washed several times with PBS, and mounted in glycerol-PBS.
In Vitro Transcription and Translation
PCR products
containing the coding region of R10 cDNA clone 50 fused to DNA
encoding the HA1 epitope were cloned into the pMOSBlue
vector (Amersham Corp.). The BamHI/HindIII
fragment was subcloned into pBluescript (pBKS) vector (Stratagene). A
DNA fragment of clone 50 containing the R10 open reading frame was
inserted into the ClaI2 shuttle vector (27). The
BamHI/EcoRI fragment was inserted into pBKS.
Plasmid DNAs were transcribed and translated using the TNT T7
reticulocyte lysate system (Promega Corp.) with [35S]L-methionine (1000 Ci/mmol; Amersham
Corp.). Translation products and their 12CA5 immunoprecipitates were
separated by SDS-PAGE and processed for fluorography.
RESULTS
Proliferating QNR Cells Infected with RAV-1 Synthesize Chimeric
mRNAs Containing Various Cellular Sequences
We searched for
the presence of chimeric mRNAs containing the leader sequence of
RAV-1 associated with cellular sequences other than
c-mil/c-raf or c-Rmil/B-raf
in a QNR culture induced to proliferate following infection with RAV-1.
Total RNA (10 µg) was reverse transcribed using an oligo(dT) primer.
Single-stranded cDNAs were further amplified by using a
leader-specific primer (L2, TCCGGTTGCTCTGCGTGATT) and a
poly(dA)-specific primer (ENT5, CGATATCGCGAT15). We cloned
the PCR products and screened bacterial colonies for hybridization with
mil/raf (28), Rmil/B-raf
(2), leader (10), and env-specific (29) probes.
We isolated two clones (clone 10 and clone 14) that hybridized only
with the leader probe and contained inserts of about 1.8 kbp. Preliminary sequence analysis showed that, as expected, these
clones contained the leader sequence of RAV-1 together with previously
unidentified cellular sequences joined to the viral splice donor
site.
Cellular sequences of Cl14 failed to detectably hybridize to RNA
extracted from various tissues of 14-day-old chicken embryos and from
cultured chicken fibroblasts, whereas those of Cl10, designated R10
thereafter, hybridized to a transcript of 1.9 kb expressed in all
tissues tested. An additional transcript of 2.3 kb was detected only in
NR cells (Fig. 1A), suggesting that R10 expression undergoes specific regulation in this tissue. To confirm this possibility, we investigated the transcription of R10 mRNAs in
NR cells at different stages of development in ovo and in
newly hatched chicks (5 days post-hatching) (Fig. 1B). Only
the 1.9-kb transcript was detected during early stages of development,
at days 6 and 8. Its levels increased between 6 and 14 days, in
ovo, and subsequently decreased to become barely detectable at
later stages of development (day 16) and in the post-hatching period. In contrast, the levels of the 2.3-kb mRNA, which was first
detectable in NR cells from 10-day-old embryos, steadily increased
during later stages of development and in newly hatched chicks (Fig. 1B). A similar pattern of expression of these two mRNAs
was also observed during embryonic development of quail neuroretina
(data not shown). Analysis of genomic DNA by Southern blotting and
hybridization indicated that the R10 sequence is derived from a single
gene spanning at least 6 kbp (Fig. 1C).
Fig. 1.
Characterization of cell-derived sequences of
cDNA clone 10 (R10 sequence). A, expression of R10 in
chicken embryonic tissues. Total RNA was extracted from different
tissues of 14-day-old chicken embryos and from cultured chicken
fibroblasts (CEF). B, expression of R10 is
regulated during NR development. Total RNA was extracted from NR cells
of 6-, 8-, 10-, 12-, 14-, 16-, 18-, and 20-day-old chicken embryos and
from newly hatched (PH) chicks. Northern blots (A
and B) containing 10 µg of each RNA were hybridized with
32P-labeled R10 probe. C, Southern blot analysis
of chicken and quail genomic DNA. Southern blot containing 10 µg of
each DNA digested with EcoRI and BamHI was
hybridized with 32P-labeled R10 probe.
[View Larger Version of this Image (47K GIF file)]
Taken together, these results indicate that QNR cells induced to
proliferate by RAV-1 synthesize chimeric mRNAs containing cellular
sequences other than c-mil/c-raf or
c-Rmil/B-raf. The cellular sequence in the
chimeric R10 transcript is derived from a gene expressed in several
avian embryonic tissues as a single mRNA species. Transcription of
the R10 gene is more complex in the NR, in which we detected
a second mRNA, and is developmentally regulated.
The R10 Gene Encodes a Protein Containing a Leucine Zipper
Motif
To identify the protein(s) encoded by the R10
gene, we screened a cDNA library prepared from oligo(dT)-primed
poly(A)+ RNA of 13-day-old embryonic QNR (16) using
cell-derived sequences of Cl10 as a probe. We isolated and
characterized four overlapping cDNA clones, which covered about 2.1 kbp. Their complexity and restriction mapping are shown in Fig.
2A.
Sequence analysis of these clones showed that they corresponded to a
cDNA of 2210 bp. Using the anchor-PCR technique on mRNA from
13-day-old embryonic QNR, we isolated 179 additional nucleotides located upstream from the identified R10 cDNA sequence. The
nucleotide sequence of the R10 cDNA, resulting from the combination
of the different clones and anchor-PCR products, is presented in Fig. 2B. This cDNA is composed of 2389 nucleotides, which is
in agreement with the apparent size (2.3 kb) of the longest transcript
expressed in NR cells of 13-day-old embryonic NR cells. It contains a
single long open reading frame beginning at nucleotide 248 and
terminating with an in-frame stop codon at nucleotide 1090. Translation
is predicted to start at the first in-frame methionine at nucleotide 335, which lies within a favorable translation initiation context (18,
19). The presence of a second translation initiation codon at
nucleotide 365 suggests the possible translation of a second
polypeptide beginning at this second methionine. Thus, the R10 cDNA
appears to consist of 334 bp of 5 untranslated region sequence which
is 53% GC rich, a coding region of 753 bp, and 1302 bp of 3
untranslated region, which contains a 24A tail and two polyadenylation
signals, 66 nucleotides apart. Comparison of the nucleotide sequence of
the four cDNA clones showed that the portion including nucleotides
856 to 882 was present only in clone 1.1, suggesting that these
sequences could represent an alternatively spliced domain.
Translation of the coding region shows that the R10 cDNA encodes a
251-amino acid polypeptide with a calculated molecular weight of
27,300. Analysis of the primary structure showed the presence of a
leucine zipper-like repeat (30, 31) spanning amino acids 88 to 116. It
consists of one leucine, one isoleucine, and three consecutively
repeated leucine residues found at seven-amino acid intervals. The
presence of this leucine zipper-like motif suggests that regions of the
R10 protein may adopt a coiled-coil structure. To further examine this
possibility, we analyzed the R10 deduced amino acid sequence using a
coiled-coil prediction program (32). This analysis confirmed that the
R10 protein has a high probability of forming a coiled-coil structure
and could, therefore, participate in protein-protein interactions
through the leucine zipper motif by adopting such a structure.
The search for nucleotide sequence homology between the R10 cDNA
and sequences compiled in the GenBank data base revealed a similarity
of 57.8% in the coding region with the human D52/N8 cDNA
corresponding to an mRNA shown to be overexpressed in breast and
lung carcinomas (6, 7). At the amino acid level, the R10 protein
displays an overall 58.6% identity with the D52 and N8 proteins (Fig.
2C).
There is an 87.1% identity between R10 and N8/D52 proteins in the
region spanning amino acids 53 to 174, which includes the leucine
zipper motif, and 93.2% in that spanning amino acids 198 to 242. The
absence of amino acids 175-197 in the human protein could result from
an alternative splicing of the human exons encoding these residues.
This is supported by the fact that these amino acids were not found in
all R10 cDNA clones and could, therefore, be encoded by an
alternatively spliced exon(s) in the quail.
Although this sequence comparison suggested that R10 is the avian
homolog of the D52/N8 human gene, we observed a
complete divergence between the carboxyl- and amino-terminal ends of
the two proteins. Thus, the 10 last amino acids of the R10 protein are
completely different from those of D52/N8 proteins. Moreover, the
amino-terminal portion of the R10 protein, spanning amino acids 1 to
52, is also totally divergent from that of N8L, which is the longest
putative protein encoded by the N8 cDNA. We considered the
possibility that this divergence could result from the exclusion, by
alternative splicing, of quail exons encoding amino acids corresponding to the human sequence. To verify this possibility, we amplified by PCR
a 3.6-kbp fragment of quail DNA using the r3 and r4 oligonucleotides as
primers. r4 is located within the common sequence, whereas r3 is
located within the R10-specific amino-terminal sequence (Fig.
2B). Nucleotide sequence analysis of the entire DNA fragment showed the presence of a splice donor site downstream from r3 and a
splice acceptor site upstream from r4 (Fig.
3B). Between these two sites, we did not
identify an open reading frame that corresponds to the amino-terminal
portion of the N8L protein.
Chimeric mRNA in RAV-1-infected QNR Cells Encodes a Truncated
R10 Protein
As mentioned above, the R10 gene was
initially identified as a hybrid mRNA containing viral and cellular
sequences. To strengthen the correlation between the synthesis of
chimeric transcripts and QNR cell proliferation, we searched for its
presence in two other QNR cultures, independently infected with RAV-1,
by using the RT-PCR technique. Five µg of total RNA from each
dividing culture were reverse transcribed using an R10-specific primer, r1 (Fig. 3). Single-stranded cDNAs were amplified by using a 5 leader-specific primer L2 and a 3 R10 primer, r2 (Fig. 3). Southern blot analysis revealed the presence of a leader-R10 amplification product of about 500 bp in both QNR cell RNAs. By sequence analysis of
PCR products obtained from one such culture, we identified three
chimeric transcripts S1, S2, and S3, in which the RAV-1 leader sequence
was linked to three different portions of the R10 sequence (Fig.
2B). In S1 and S3, the translation initiation codon of the
gag gene is not in-frame with the downstream R10 sequences,
indicating that these RNAs do not encode polypeptides. In contrast, S2
contains a single long open reading frame encoding a putative fusion
protein of 144 amino acids composed of the six first amino acids of
RAV-1 Gag and the last 138 amino acids of R10 (Fig. 3A). The
fusion of Gag amino acids with the R10 protein, which disrupts the
leucine zipper motif, results in the substitution of the first leucine
of this motif by a valine and of the following alanine by an
isoleucine. These substitutions do not modify the capacity of the
hybrid protein to adopt a coiled-coil structure, as indicated by
computer analysis (32). However they could modify its dimerization
specificity in comparison to that of the full-length R10 protein.
We compared the nucleotide sequences of S1, S2, and S3 cDNAs to
that of R10 cDNA and we found that the region located between nucleotides 856 and 882, which is absent in R10 cDNA clones 80, 8, and 50 (Fig. 2A), also is absent in S1 and S3 cDNAs. In S2, this
deletion is extended up to nucleotide 924, suggesting that this region
could correspond to alternatively spliced exons.
These results show that proliferating RAV-1-infected QNR cells
synthesize, at least, three chimeric R10 mRNAs, one of which encodes a truncated protein. According to the general mechanism we
proposed previously (5), these RNAs should be generated following the
frequent integration of RAV-1 provirus, either upstream from or within
the R10 gene, and subsequent alternative splicing of a
primary readthrough transcript containing at least five exons located
downstream from the provirus. To confirm this hypothesis, we analyzed
sequences of the quail R10 gene containing the S1, S2, and
S3 junction sites. Therefore, we amplified regions of quail genomic DNA
using r3 and r4 as primers flanking the S1 site, r5 and r6 as primers
flanking the S2 site, and r7 and r8 primers flanking the S3 site (Fig.
2B). We obtained amplified DNA fragments of 3.6, 1.2, and
0.9 kbp, respectively, which were subcloned into the
pMOSBlue vector and sequenced. We found that all three S1, S2, and S3 junction sites correspond to consensus sequences for splice
acceptor sites (Fig. 3B). This confirms that the hybrid R10
mRNAs are generated by a splicing process joining the splice donor
site of RAV-1 leader to acceptor sites of R10 exons, analogous to the
mechanism described for the synthesis of
c-mil/c-raf and c-Rmil/B-raf spliced readthrough transcripts
(5).
Characterization and Subcellular Localization of the R10 Gene
Product
To identify the R10 gene product, we generated
polyclonal rabbit antisera directed against two different regions of
the protein encoded by the R10 cDNA. The first antiserum,
designated PR, was prepared against amino acids 26 to 64. The second,
designated LZ, was prepared against amino acids 67 to 132, which
include the leucine zipper motif. To assess the specificity of these
antisera, we also constructed an expression vector synthesizing an
epitope-tagged R10 protein. Therefore, we introduced at the 3 end of
the coding region of the R10 cDNA clone 50 a DNA fragment
encoding the nine-residue epitope of influenza virus hemagglutinin HA1,
which is recognized by the 12CA5 monoclonal antibody. The pECE
expression vector (Fig. 4A) containing this
recombinant DNA was used to transfect COS-1 cells. Cell lysates,
prepared 48 h later, were immunoprecipitated with the 12CA5
antibody, and immune complexes were tested for the presence of the R10
protein by Western blotting using the same antibody. We detected two
proteins, with apparent molecular weights of 32.5 and 29 kDa,
respectively, in immunoprecipitates of cells transfected with the
vector expressing the HA1-tagged R10 protein but not in lysates of
cells transfected with the control pECE vector (Fig. 4B).
The same proteins were revealed by Western blotting with the anti-LZ
antibody (data not shown). Likewise, the 32.5- and 29-kDa proteins were
detected by immunoprecipitation with either anti-PR or anti-LZ serum
and immunoblotting with 12CA5 (Fig. 4B). Proteins migrating
at the same molecular weights were also detected in lysates of
HA1-tagged R10-transfected cells, immunoprecipitated with either
anti-PR or anti-LZ serum, and revealed by Western blotting with the
anti-LZ antibody. R10 proteins were not detected in lysates
immunoprecipitated with preimmune sera, nor in those from cells
transfected with the control vector (Fig. 4C).
To characterize the endogenous avian R10 protein(s), we
immunoprecipitated lysates of quail or chicken embryonic fibroblasts or
NR cells from 16-day-old embryos with either anti-PR (data not shown)
or anti-LZ (Fig. 5) serum and subjected the
immunoprecipitates to Western blotting with the anti-LZ antibody. In
chicken and quail embryonic fibroblasts, we identified a single protein
with an apparent molecular weight of 23,000, whereas a second protein of 30,000 was detected in post-mitotic NR cells. These proteins were
not detected in cell lysates treated with preimmune sera.
Fig. 5.
Characterization of the endogenous R10
protein. Chicken embryonic fibroblasts (CEF), quail
embryonic fibroblasts (QEF), and 16-day-old embryo NR
extracts (250 µg) were immunoprecipitated (IP) with
preimmune (PI) serum or with anti-LZ antisera.
Immunoprecipitates were analyzed by SDS-PAGE (CEF and QEF, 15% gels;
NR, 12% gels) and revealed (WB, immunoblots) with the
anti-LZ antisera.
[View Larger Version of this Image (68K GIF file)]
We also investigated by immunofluorescence the subcellular localization
of the R10 protein. Therefore, COS-1 cells were transfected with the
vector expressing the HA1-tagged R10 protein and immunostained 48 h later with either the 12CA5 monoclonal antibody or the LZ anti-serum
and subsequently with a fluorescein-conjugated secondary antibody. Five
to ten % of transfected cells expressed a strong fluorescence
concentrated in the cytoplasm, whereas the nucleus appeared as a dark
area (Fig. 6), in comparison to control COS-1 cells
overexpressing a nuclear protein (data not shown).
Fig. 6.
Subcellular localization of the R10
protein. COS-1 cells transiently transfected with pECE vector
alone (A and B) or with the HA1-R10
protein-expressing vector (C and D) were
immunostained with the LZ antibody and the fluorescein isothiocyanate
secondary antibody as described under "Experimental Procedures."
Cells were observed under phase contrast (A and
C) and UV light (B and D).
[View Larger Version of this Image (165K GIF file)]
The R10 Protein Forms Homodimers
To study the possible
participation of the R10 gene product in protein-protein
interactions, we tested the ability of in vitro translated
proteins to form dimers. Therefore, we used constructs expressing
either the R10 protein (Cl50 cDNA) or its HA1-tagged version, which
is expected to migrate at a different position. The proteins were
translated, alone or simultaneously, using
messenger-dependent rabbit reticulocyte lysates.
Radioactively labeled translation products were analyzed by SDS-PAGE
either directly or following immunoprecipitation with anti-HA1
antibodies. R10 and HA1-tagged proteins were identified as single bands
migrating at 30 and 31.5 kDa, respectively, when translated alone and
as two distinguishable bands when cotranslated (Fig.
7A). Resolution of immunoprecipitates of
samples in which the two proteins were cotranslated showed that the HA1
antibody was able to bring down both tagged and nontagged proteins
(Fig. 7B). We also investigated whether the full-length protein was able to dimerize with the truncated protein encoded by the
chimeric RNA. In this experiment, we used the HA1-tagged version of the
truncated protein. Analysis of complexes obtained by
immunoprecipitation of lysates from cotranslation samples revealed the
presence of the tagged R10 hybrid protein alone (data not shown). These
results show that the R10 protein is capable to form homodimers, likely
through its leucine zipper motif, whereas it cannot interact with the
truncated protein encoded by chimeric mRNAs expressed in
proliferating QNR cells infected with RAV-1. This suggests that the
full-length and the truncated proteins are not associated in these
cells.
Fig. 7.
The R10 protein forms homodimers.
Plasmid DNAs containing R10 cDNA (pR10) and tagged-R10
cDNA (pR10/HA-1) were translated separately or together
in an in vitro transcription/translation system as described
under "Experimental Procedures." Control aliquots (5 µl)
(A) and aliquots (45 µl) immunoprecipitated with the 12CA5 antibody (B) were analyzed by SDS-PAGE and processed for
fluorography.
[View Larger Version of this Image (39K GIF file)]
DISCUSSION
Transcriptional activation and subsequent transduction of cellular
genes is a multistep process that reproducibly leads to the sustained
proliferation of post-mitotic avian NR cells infected with retroviruses
that do not carry an oncogene (5, 33). This in vitro
experimental model has proved useful in the characterization of
molecular intermediates during retroviral transduction of cellular genes. It also provides a valuable means to identify retrovirally activated genes, potentially involved in regulation of NR cell growth
or differentiation. We have isolated from QNR cells induced to
proliferate by RAV-1 chimeric mRNAs resulting from a splice junction between the viral donor site and the acceptor sites of three
exons of a gene, designated R10. The R10 locus
appears to represent a frequent integration site of RAV-1 in QNR cells,
because these mRNAs were isolated from three cultures independently
infected with RAV-1. R10 chimeric RNAs are likely to result from the
alternative splicing of a primary readthrough transcript and are,
therefore, generated according to the general mechanism we proposed
previously for the synthesis of similar RNAs containing the
c-mil/c-raf and c-Rmil/B-raf oncogenes in RAV-1-infected chicken
NR cells (5).
The R10 cDNA (clone 50) encodes a protein of a calculated molecular
weight of 27,300. This is in agreement with the 30 kDa product
generated by its in vitro transcription-translation and with
the size of the larger protein found in post-mitotic NR cells. These
cells contain two transcripts of 1.9 and 2.3 kb. In contrast, a 23-kDa
protein was detected in fibroblasts expressing only the 1.9-kb
mRNA. This protein is likely to be the product of an alternatively spliced mRNA.
In COS-1 cells transfected with the HA1-tagged R10 cDNA, we
detected two proteins of 32.5 and 29 kDa. The synthesis of two proteins
could result either from alternative initiation of translation on
either ATG identified in the R10 open reading frame or from posttranslational modifications.
R10 protein contains in its mid-region a leucine zipper motif. In
proliferating cells, the chimeric R10 mRNA potentially encodes a
truncated Gag-R10 protein, which retains this motif. Both proteins show
a propensity to adopt coiled-coil structure, suggesting that they are
involved in homophilic or heterophilic protein-protein interactions.
In general, leucine zipper-containing proteins can be divided into two
groups. The first one essentially includes the bZip transcription
factors, characterized by the presence of a basic region immediately
upstream from the leucine zipper motif. Several proteins of this group,
such as Jun, Fos, or Maf, were first identified as the oncogenic
products of acutely transforming retroviruses (34, 35, 36, 37, 38, 39, 40). They act as
positive or negative regulators of cellular proliferation. They can
also control tissue-specific functions by regulating the expression of
specific target genes. Thus, the retina-specific member of the Maf
family, NRL, positively regulates rhodopsin gene expression (41,
42).
The second group assembles various proteins devoid of basic region.
Proteins such as MLK1, MLK2 (43), MLK3/SPRK/PTK1 (44, 45, 46), and DLK (47)
have a putative dual function defined by the presence of both kinase
and leucine zipper domains. Non-basic leucine zipper proteins were also
shown to participate in embryogenesis and eye morphogenesis. Thus, the
leucine zipper TOPap protein is involved in retinotectal polarity and
establishment of specific retinotectal synaptic connections during
chicken embryonal development (48). Another leucine zipper protein,
Shs, is involved in differentiation of the Drosophila eye
photoreceptors (49). However, involvement of these polypeptides in
protein-protein interactions through their leucine zipper has not yet
been demonstrated.
The R10 gene product is a cytoplasmic protein that lacks
basic amino acids commonly found in bZip proteins and is expressed in
various tissues. However, its transcription pattern is more complex and
is developmentally regulated in the NR, since the expression of each of
the two R10 transcripts seems to correlate with specific stages of NR
differentiation. The leucine zipper-containing region of R10 is
strongly homologous to the putative human D52/N8 protein. The mRNA
encoding this protein was shown to be overexpressed in various human
tumors of epithelial origin (6, 7). Although this suggested that the
R10 gene is the avian homolog of the
D52/N8 human gene, we found that the amino- and
carboxyl-terminal ends of R10 and N8L proteins are completely
different. We also showed that sequences encoding the amino-terminal
human-specific amino acids were not present in the quail R10
gene, immediately upstream from the region common to both proteins. It
remains possible that these sequences could be encoded by exons located
further upstream and that the N8L mRNA would result from the
alternative splicing of these exons. However, we cannot exclude that
the R10 and N8L proteins are the products of different, but related,
genes. More detailed structural analysis is needed to clarify the
nature and biological significance of this divergence in the
amino-terminal sequence of the two proteins.
We have shown that the R10 protein can readily homodimerize, whereas it
cannot apparently form dimers with its truncated Gag-R10 counterpart.
These results, however, do not rule out the possibility that it could
also dimerize with other proteins. Therefore, identification of
interacting proteins and characterization of its biological properties
should help in understanding the function of the R10 gene
product.
FOOTNOTES
*
This work was funded by the Centre National de la Recherche
Scientifique, the Institut Curie, and the Association pour la Recherche
sur le Cancer. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) Y07757[GenBank].
Supported by a fellowship from the Ligue Nationale contre le
Cancer.
§
To whom correspondence should be addressed. Tel.: 33 1 69 86 30 72;
Fax: 33 1 69 07 45 25; E-mail: marx{at}curie.u-psud.fr.
1
The abbreviations used are: NR, neuroretina;
RAV-1, Rous-associated virus type 1; QNR, quail embryonic NR; PCR,
polymerase chain reaction; PBS, phosphate-buffered saline; kbp,
kilobase pair(s); bp, base pair(s); PAGE, polyacrylamide gel
electrophoresis.
2
M. P. Felder-Schmittbuhl, D. Laugier, and G. Calothy, unpublished results.
Acknowledgment
We thank F. Arnouilh for help in preparation
of the manuscript.
REFERENCES
-
van Lohuizen, M., and Berns, A.
(1990)
Biochim. Biophys. Acta
1032,
213-235
[Medline]
[Medline]
[Order article via Infotrieve]
-
Marx, M., Eychene, A., Laugier, D., Bechade, C., Crisanti, P., Dezelee, P., Pessac, B., and Calothy, G.
(1988)
EMBO J.
7,
3369-3373
[Medline]
[Medline]
[Order article via Infotrieve]
-
Marx, M., Crisanti, P., Eychene, A., Bechade, C., Laugier, D., Ghysdael, J., Pessac, B., and Calothy, G.
(1988)
J. Virol.
62,
4627-4633
[Medline]
[Abstract/Free Full Text]
-
Felder, M. P., Eychene, A., Barnier, J. V., Calogeraki, I., Calothy, G., and Marx, M.
(1991)
J. Virol.
65,
3633-3640
[Medline]
[Abstract/Free Full Text]
-
Felder, M. P., Laugier, D., Eychene, A., Calothy, G., and Marx, M.
(1993)
J. Virol.
67,
6853-6856
[Medline]
[Abstract/Free Full Text]
-
Byrne, J. A., Tomasetto, C., Garnier, J. M., Rouyer, N., Mattei, M. G., Bellocq, J. P., Rio, M. C., and Basset, P.
(1995)
Cancer Res.
55,
2896-2903
[Medline]
[Abstract/Free Full Text]
-
Chen, S., Maroulakou, I., Green, J., Romano-Spica, V., Modi, W., Lautenberger, J., and Bhat, N.
(1996)
Oncogene
12,
741-751
[Medline]
[Medline]
[Order article via Infotrieve]
-
Pessac, B., and Calothy, G.
(1974)
Science
185,
709-710
[Medline]
[Abstract/Free Full Text]
-
Bechade, C., Dambrine, G., David-Pfeuty, T., Esnault, E., and Calothy, G.
(1988)
J. Virol.
62,
1211-1218
[Medline]
[Abstract/Free Full Text]
-
Felder, M. P., Laugier, D., Yatsula, B., Dezelee, P., Calothy, G., and Marx, M.
(1994)
J. Virol.
68,
4759-4767
[Medline]
[Abstract/Free Full Text]
-
Gross-Bellard, M., Oudet, P., and Chambon, P.
(1973)
Eur. J. Biochem.
36,
32-38
[Medline]
[Medline]
[Order article via Infotrieve]
-
Southern, E. M.
(1975)
J. Mol. Biol.
98,
503-517
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wahl, G. M., Stern, M., and Stark, G. R.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
3683-3687
[Medline]
[Abstract/Free Full Text]
-
Sambrook, J., Fritsch, E., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J.
(1979)
Biochemistry
18,
5294-5299
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Guermah, M., Gillet, G., Michel, D., Laugier, D., Brun, G., and Calothy, G.
(1990)
Mol. Cell. Biol.
10,
3584-3590
[Medline]
[Abstract/Free Full Text]
-
Sanger, F.
(1981)
Science
214,
1205-1210
[Medline]
[Free Full Text]
-
Kozak, M.
(1987)
Nucleic Acids Res.
15,
8125-8148
[Medline]
[Abstract/Free Full Text]
-
Kozak, M.
(1992)
Annu. Rev. Cell Biol.
8,
197-225
[Medline]
[CrossRef]
-
Meloche, S., Pages, G., and Pouyssegur, J.
(1992)
Mol. Biol. Cell
3,
63-71
[Medline]
[Abstract]
-
Boulukos, K. E., Pognonec, P., Begue, A., Galibert, F., Gesquiere, J. C., Stehelin, D., and Ghysdael, J.
(1988)
EMBO J.
7,
697-705
[Medline]
[Medline]
[Order article via Infotrieve]
-
Barnier, J. V., Papin, C., Eychene, A., Lecoq, O., and Calothy, G.
(1995)
J. Biol. Chem.
270,
23381-23389
[JBC][Medline]
[Abstract/Free Full Text]
-
Remaut, E., Stanssens, P., and Fiers, W.
(1981)
Gene (Amst.)
15,
81-93
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ghysdael, J., Gegonne, A., Pognonec, P., Dernis, D., Leprince, D., and Stehelin, D.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
1714-1718
[Medline]
[Abstract/Free Full Text]
-
Harlow, E., and Lane, D.
(1988)
Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Wilson, I. A., Niman, H. L., Houghten, R. A., Cherenson, A. R., Connolly, M. L., and Lerner, R. A.
(1984)
Cell
37,
767-778
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hughes, S. H., Greenhouse, J. J., Petropoulos, C. J., and Sutrave, P.
(1987)
J. Virol.
61,
3004-3012
[Medline]
[Abstract/Free Full Text]
-
Coll, J., de Taisne, C., Dissous, C., Gegonne, A., and Stehelin, D.
(1983)
EMBO J.
2,
2189-2194
[Medline]
[Order article via Infotrieve]
-
Stavnezer, E., Gerhard, D. S., Binari, R. C., and Balazs, I.
(1981)
J. Virol.
39,
920-934
[Medline]
[Abstract/Free Full Text]
-
Landschulz, W. H., Johnson, P. F., and McKnight, S. L.
(1988)
Science
240,
1759-1764
[Medline]
[Abstract/Free Full Text]
-
Alber, T.
(1992)
Curr. Opin. Genet. Dev.
2,
205-210
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lupas, A., Van Dyke, M., and Stock, J.
(1991)
Science
252,
1162-1164
[Medline]
[Free Full Text]
-
Felder, M. P., Eychene, A., Laugier, D., Marx, M., Dezelee, P., and Calothy, G.
(1994)
Folia Biol. (Praha)
40,
225-235
[Medline]
[Medline]
[Order article via Infotrieve]
-
Maki, Y., Bos, T. J., Davis, C., Starbuck, M., and Vogt, P. K.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
2848-2852
[Medline]
[Abstract/Free Full Text]
-
Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., and Tjian, R.
(1987)
Science
238,
1386-1392
[Medline]
[Abstract/Free Full Text]
-
Curran, T., Peters, G., Van Beveren, C., Teich, N. M., and Verma, I. M.
(1982)
J. Virol.
44,
674-682
[Medline]
[Abstract/Free Full Text]
-
Van Beveren, C., van Straaten, F., Curran, T., Muller, R., and Verma, I. M.
(1983)
Cell
32,
1241-1255
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sambucetti, L. C., Curran, T., Angel, P., and Karin, M.
(1986)
Science
234,
1417-1419
[Medline]
[Abstract/Free Full Text]
-
Nishizawa, M., Kataoka, K., Goto, N., Fujiwara, K. T., and Kawai, S.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7711-7715
[Medline]
[Abstract/Free Full Text]
-
Kawai, S., Goto, N., Kataoka, K., Saegusa, T., Shinno-Kohno, H., and Nishizawa, M.
(1992)
Virology
188,
778-784
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Swaroop, A., Xu, J. Z., Pawar, H., Jackson, A., Skolnick, C., and Agarwal, N.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
266-270
[Medline]
[Abstract/Free Full Text]
-
Rehemtulla, A., Warwar, R., Kumar, R., Ji, X., Zack, D. J., and Swaroop, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
191-195
[Medline]
[Abstract/Free Full Text]
-
Dorow, D. S., Devereux, L., Dietzsch, E., and De Kretser, T.
(1993)
Eur. J. Biochem.
213,
701-710
[Medline]
[Medline]
[Order article via Infotrieve]
-
Ing, Y. L., Leung, I. W., Heng, H. H., Tsui, L. C., and Lassam, N. J.
(1994)
Oncogene
9,
1745-1750
[Medline]
[Medline]
[Order article via Infotrieve]
-
Gallo, K. A., Mark, M. R., Scadden, D. T., Wang, Z., Gu, Q., and Godowski, P. J.
(1994)
J. Biol. Chem.
269,
15092-15100
[Medline]
[Abstract/Free Full Text]
-
Ezoe, K., Lee, S. T., Strunk, K. M., and Spritz, R. A.
(1994)
Oncogene
9,
935-938
[Medline]
[Medline]
[Order article via Infotrieve]
-
Holzman, L. B., Merritt, S. E., and Fan, G.
(1994)
J. Biol. Chem.
269,
30808-30817
[Medline]
[Abstract/Free Full Text]
-
Savitt, J. M., Trisler, D., and Hilt, D. C.
(1995)
Neuron
14,
253-261
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Treisman, J. E., Lai, Z. C., and Rubin, G. M.
(1995)
Development
121,
2835-2845
[Medline]
[Abstract]
-
Breathnach, R., and Chambon, P.
(1981)
Annu. Rev. Biochem.
50,
349-383
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Lewis, L. A. Payton, J. G. Whitford, J. A. Byrne, D. I. Smith, L. Yang, and R. K. Bright
Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein D52
Mol. Cancer Res.,
February 1, 2007;
5(2):
133 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cho, H.-M. Ko, J.-M. Kim, J.-A Lee, J.-E. Park, M.-S. Jang, S. G. Park, D. H. Lee, S.-E. Ryu, and B.-C. Park
Positive Regulation of Apoptosis Signal-regulating Kinase 1 by hD53L1
J. Biol. Chem.,
April 16, 2004;
279(16):
16050 - 16056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, J. Xu, O. Saramaki, T. Visakorpi, W. M. Sutherland, J. Zhou, B. Sen, S. D. Lim, N. Mabjeesh, M. Amin, et al.
PrLZ, a Novel Prostate-Specific and Androgen-Responsive Gene of the TPD52 Family, Amplified in Chromosome 8q21.1 and Overexpressed in Human Prostate Cancer
Cancer Res.,
March 1, 2004;
64(5):
1589 - 1594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Groblewski, M. Yoshida, H. Yao, J. A. Williams, and S. A. Ernst
Immunolocalization of CRHSP28 in exocrine digestive glands and gastrointestinal tissues of the rat
Am J Physiol Gastrointest Liver Physiol,
January 1, 1999;
276(1):
G219 - G226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. H. Thomas, W. B. Taft, K. M. Kaspar, and G. E. Groblewski
CRHSP-28 Regulates Ca2+-stimulated Secretion in Permeabilized Acinar Cells
J. Biol. Chem.,
July 27, 2001;
276(31):
28866 - 28872.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|